Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphomaSteven M Devine, Neal Flomenberg, David H Vesole, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocolIvana N Micallef, Patrick J Stiff, John F DiPersio, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2009
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1Graeme Moyle, Edwin DeJesus, Marta Boffito, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2013
Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cellsRichard T Maziarz, Auayporn P Nademanee, Ivana N Micallef, et al.Cytotherapy|November 26, 2009
Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular diseaseArnon Blum, Richard W Childs, Aleah Smith, et al.Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.Transfusion|March 9, 2005
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonistW Conrad Liles, Elin Rodger, Hal E Broxmeyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphomaJohn F DiPersio, Ivana N Micallef, Patrick J Stiff, et al.AIDS Research and Human Retroviruses|May 18, 2019
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210Victoria A Johnson, Yoninah S Cramer, Susan L Rosenkranz, et al.Blood|July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.Pageof 3